Articles related to Gynecologic Oncology

Recent compensation surveys place average U.S. oncologist earnings between approximately $360,000 and $465,000 annually, with variation driven by subspecialty, geography, experience level, and persistent demographic pay disparities.

ASCO released updated recommendations for recurrent ovarian cancer that reinforce platinum-based doublet therapy as the preferred approach for platinum-sensitive disease and provide guidance for platinum-resistant disease, maintenance strategies, and monitoring. Recommendations were derived from a systematic review of studies published through 2025.

A high-sensitivity KRAS-targeted blood test detects residual pancreatic cancer missed by standard assays, suggesting current monitoring approaches may underestimate recurrence risk despite treatment.

US cancer centers are enrolling fewer patients in clinical trials despite continued global therapeutic advances, raising concerns about access, competitiveness, and whether trials are fully integrated into standard oncology care.

PCOS was associated with significantly elevated risk for breast, uterine, ovarian/fallopian tube, and cervical cancers in a matched cohort of more than 2.5 million women.